The Hip Replacement Market, estimated at USD 7.8 Bn in 2025, is expected to exhibit a CAGR of 5.5% and reach USD 11.35 Bn by 2032.
The industry is witnessing significant growth driven by rising demand for advanced, reliable, and cost-effective medical devices across diagnostic, therapeutic, and monitoring applications. Rapid advancements in device design, digital health integration, and adoption of minimally invasive technologies are reshaping the competitive landscape. Furthermore, supportive regulatory frameworks, increasing healthcare investments, and the growing focus on patient-centric care are expected to create new growth avenues for market players.
To bring patient-centered, high-quality care to more communities, the various market players are engaged in adoption of growth strategies, which is expected to offer significant growth opportunities for players in the global hip replacement market. For instance, on January 27, 2025 MicroPort, a medical device company in China, received national medical product administration marketing approval for Profemur preserve hip stem. The Profemur Preserve Hip Stem is the latest generation hip stem with metaphyseal fixation, intended to provide a more stable solution for an increasingly younger patient population.
Global Hip Replacement Market – Impact of Coronavirus (COVID-19) Pandemic
Since the outbreak of the COVID-19 epidemic in December 2025, the disease has spread to more than 100 countries worldwide and has been declared a public health emergency by the World Health Organization. The emergence of the coronavirus (COVID-19) had claimed more than 27 million lives worldwide, according to a report by the World Health Organization. The COVID pandemic has changed the homeostasis of the medical world and is affecting millions of people worldwide. The global crisis has consequences for the world economy in addition to health. On 15 May 2025, the British Orthopedic Association (BOA), Surgical Specialty Association, U.K. produced a document to help doctors resume orthopedic care. 7 Establishment of COVID-free and COVID-controlled patient care pathways was proposed. To ensure the safety of patients undergoing elective surgery, the BOA sought to communicate this information to patients by issuing guidance specific to patients undergoing arthroplasty on June 26, 2025.
Global Hip Replacement Market: Key Developments
On January 27, 2025 MicroPort, a medical device company based in China, received national medical product administration marketing approval for its Procotyl-L Acetabular Cup System. The Procotyl-L Acetabular System is an improved version of the Lineage Acetabular series that was first introduced to the European market in 2006. The Procotyl-L cup is constructed of an irregularly stratified pore layer of titanium alloy, biocompatible material, and titanium bead coating.